These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

350 related items for PubMed ID: 17496396

  • 1. The Gulf Survey on Anemia Management (GSAM 2005).
    Alsuwaida A, Abdulkareem A, Alwakeel J.
    Saudi J Kidney Dis Transpl; 2007 Jun; 18(2):206-14. PubMed ID: 17496396
    [Abstract] [Full Text] [Related]

  • 2. Monitoring iron status in end-stage renal disease patients on hemodialysis.
    Rafi A, Karkar A, Abdelrahman M.
    Saudi J Kidney Dis Transpl; 2007 Mar; 18(1):73-8. PubMed ID: 17237895
    [Abstract] [Full Text] [Related]

  • 3. Association between transferrin receptor-ferritin index and conventional measures of iron responsiveness in hemodialysis patients.
    Chen YC, Hung SC, Tarng DC.
    Am J Kidney Dis; 2006 Jun; 47(6):1036-44. PubMed ID: 16731299
    [Abstract] [Full Text] [Related]

  • 4. Hemodialysis delivery, dialysis dose achievement, and vascular access types in hemodialysis patients from the Gulf Cooperation Council countries enrolled in the dialysis outcomes and practice patterns study phase 5 (2012-2015).
    AlYousef A, AlGhareeb S, Al Wakeel J, Al-Ghamdi SM, Bieber BA, Hassan M, Al Maimani Y, Alkandari N, Ahmed HZ, Fawzy A, Pisoni RL, GCC-DOPPS 5 Study GroupList of Study Group in Acknowledgment..
    Saudi J Kidney Dis Transpl; 2016 Nov; 27(6 Suppl 1):S42-50. PubMed ID: 27991478
    [Abstract] [Full Text] [Related]

  • 5. Association of reproductive factors with the incidence of breast cancer in Gulf Cooperation Council countries.
    Ravichandran K, Al-Zahrani AS.
    East Mediterr Health J; 2009 Nov; 15(3):612-21. PubMed ID: 19731777
    [Abstract] [Full Text] [Related]

  • 6. Effect of intravenous ascorbic acid in hemodialysis patients with EPO-hyporesponsive anemia and hyperferritinemia.
    Attallah N, Osman-Malik Y, Frinak S, Besarab A.
    Am J Kidney Dis; 2006 Apr; 47(4):644-54. PubMed ID: 16564942
    [Abstract] [Full Text] [Related]

  • 7. Should we limit the ferritin upper threshold to 500 ng/ml in CKD patients?
    Dukkipati R, Kalantar-Zadeh K.
    Nephrol News Issues; 2007 Jan; 21(1):34-8. PubMed ID: 17269263
    [Abstract] [Full Text] [Related]

  • 8. [Is the management of anemia in hemodialysis patients improving in France? Results of the DiaNE study].
    Kessler M, Landais P, Canivet E, Yver L, Bataille P, Brillet G, Commenges B, Koné S.
    Nephrol Ther; 2009 Apr; 5(2):114-21. PubMed ID: 19042175
    [Abstract] [Full Text] [Related]

  • 9. Cardiovascular and cerebrovascular comorbidities in hemodialysis patients from the Gulf Cooperation Council countries enrolled in the dialysis outcome and practice pattern study phase 5 (2012-2015).
    Shaheen FA, Al Wakeel J, Al-Ghamdi SM, Alhelal B, AlGhareeb S, Al Obaidli AA, AlSalmi I, Abdulaziz HE, Bieber BA, Pisoni RL, GCC-DOPPS 5 Study GroupList of Study Group in Acknowledgement..
    Saudi J Kidney Dis Transpl; 2016 Nov; 27(6 Suppl 1):S24-30. PubMed ID: 27991476
    [Abstract] [Full Text] [Related]

  • 10. Mineral bone disorder and its management among hemodialysis patients in the Gulf Cooperation Council: Initial findings from the dialysis outcomes and practice patterns study (2012-2015).
    Al Salmi I, AlRukhaimi M, AlSahow A, Shaheen FA, Al-Ghamdi SM, AlAli F, AlGhareeb S, Al Maimani Y, AlGhonaim M, Bieber B, Tentori F, Pisoni RL, GCC-DOPPS 5 Study GroupStudy Group in Acknowledgment..
    Saudi J Kidney Dis Transpl; 2016 Nov; 27(6 Suppl 1):62-80. PubMed ID: 27991480
    [Abstract] [Full Text] [Related]

  • 11. Soluble transferrin receptors and reticulocyte hemoglobin concentration in the assessment of iron deficiency in hemodialysis patients.
    Fusaro M, Munaretto G, Spinello M, Rebeschini M, Amici G, Gallieni M, Piccoli A.
    J Nephrol; 2005 Nov; 18(1):72-9. PubMed ID: 15772926
    [Abstract] [Full Text] [Related]

  • 12. Intravenous iron in chronic kidney disease: haemoglobin change shortly after treatment of patients neither on dialysis nor on erythropoietin.
    Tagboto S, Cropper L, Mostafa S, Turner J, Bailey G, Pugh-Clarke K.
    J Ren Care; 2008 Sep; 34(3):112-5. PubMed ID: 18786076
    [Abstract] [Full Text] [Related]

  • 13. Effect of variability in anemia management on hemoglobin outcomes in ESRD.
    Lacson E, Ofsthun N, Lazarus JM.
    Am J Kidney Dis; 2003 Jan; 41(1):111-24. PubMed ID: 12500228
    [Abstract] [Full Text] [Related]

  • 14. Renal anemia: comparing current Eastern and Western European management practice (ORAMA).
    Wiecek A, Covic A, Locatelli F, Macdougall IC, ORAMA study group.
    Ren Fail; 2008 Jan; 30(3):267-76. PubMed ID: 18350446
    [Abstract] [Full Text] [Related]

  • 15. Gulf Cooperation Council-dialysis outcomes and practice patterns study: An overview of anemia management trends at the regional and country specific levels in the Gulf Cooperation Council countries.
    Abouchacra S, Obaidli A, Al-Ghamdi SM, Al Wakeel J, Al Salmi I, Al Ghareeb S, Al Azmi M, Elsayed M, Bieber BA, Pisoni RL, GCC-DOPPS 5 Study GroupList of Study Group in Acknowledgment..
    Saudi J Kidney Dis Transpl; 2016 Nov; 27(6 Suppl 1):51-61. PubMed ID: 27991479
    [Abstract] [Full Text] [Related]

  • 16. [Treatment of renal anemia with iron in hemodialysis patients in General Hospital Bjelovar].
    Lovcić V, Vujić J, Basić-Jukić N, Janković RI, Kurtović I, Dzapo M, Lovcić P.
    Acta Med Croatica; 2011 Oct; 65 Suppl 3():45-8. PubMed ID: 23120815
    [Abstract] [Full Text] [Related]

  • 17. Predialysis Survey on Anemia Management: patient referral.
    Hörl WH, Macdougall IC, Rossert J, Rutkowski B, Wauters JP, Valderrábano F, Predialysis Survey on Anemia Management.
    Am J Kidney Dis; 2003 Jan; 41(1):49-61. PubMed ID: 12500221
    [Abstract] [Full Text] [Related]

  • 18. Management of iron deficiency in renal anemia: guidelines for the optimal therapeutic approach in erythropoietin-treated patients.
    Drüeke TB, Bárány P, Cazzola M, Eschbach JW, Grützmacher P, Kaltwasser JP, Macdougall IC, Pippard MJ, Shaldon S, van Wyck D.
    Clin Nephrol; 1997 Jul; 48(1):1-8. PubMed ID: 9247771
    [Abstract] [Full Text] [Related]

  • 19. Role of C-reactive protein, reticulocyte haemoglobin content and inflammatory markers in iron and erythropoietin administration in dialysis patients.
    El-Khatib M, Duncan HJ, Kant KS.
    Nephrology (Carlton); 2006 Oct; 11(5):400-4. PubMed ID: 17014552
    [Abstract] [Full Text] [Related]

  • 20. Caring for the renal failure patient: optimizing iron therapy.
    Folkert VW, Javier AM, O'Mara NB.
    Nephrol Nurs J; 2002 Dec; 29(6):586-93; quiz 594-5. PubMed ID: 12596608
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.